Antares Pharma Inc (USD)
ATRS
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range3.49 | 3.65
52-Wk Range2.60 | 5.13
Last Close3.57
Mkt Cap (m)582.72
Dividend yield-
ISINUS0366421065
Volume979,708
Exchange VenueNAS

Company Profile

Antares Pharma Inc is a specialty pharmaceutical company. It is engaged in developing and commercializing self-administered parenteral pharmaceutical products and technologies including novel, pressure-assisted injectors.

Key Information
Price/Earning-
Price/Book13.12
Price/Sales5.49
P/CF-
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % -
Net Margin %-
Return on Equity-
Debt/Equity-

Documents

Prospectus
en 11/08/2017
Annual Report
en 31/12/2018

Financials

Income Statement
USD201420152016201720182019
Revenue (m)2746525564-
Operating Income (m)-35-20-24-16-17-
Net Income (m)-35-21-24-17-7-
Basic EPS-0.27-0.14-0.16-0.11-0.04-
Avg. Diluted Shares Outstanding (m)131147155156157-
Balance Sheet
USD201420152016201720182019
Current Assets (m)5466455671-
Non Current Assets (m)1519211917-
Total Assets (m)6985667488-
Current Liabilities (m)2417201627-
Total Liabilities (m)------
Total Equity (m)4167453439-
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)-26-28-15-23-17-
Capital Expenditure (m)-6-7-5-1-1-
Figures are quoted in USD unless stated otherwise
-0.05 (-1.40%)
$
3.52
Last Price